Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Fibroblast growth factor 7 pseudogene 7 (FGF7P7)** is annotated as a pseudogene related to the protein-coding gene Fibroblast growth factor 7 (FGF7), also known as keratinocyte growth factor. Pseudogenes such as FGF7P7 are generally considered non-coding genomic DNA segments that resemble functional genes but are typically not transcribed into functional proteins. Current database and literature searches do not support FGF7P7 as a functional gene or therapeutic target; there are no known biological roles, drug interactions, or clinical implications directly ascribed to FGF7P7. Its classification as a pseudogene, rather than a protein-coding target, means it should not be considered a canonical receptor, enzyme, transporter, or other classical therapeutic target[2]. Given the lack of evidence for any functional/therapeutic role or protein product, this entity is best considered a non-target and may exist only as a genomic annotation. **NOTES on correctness:** - There is no evidence for FGF7P7 being a protein-coding gene, receptor, or therapeutic target; therefore, it should not be used as such in structured biomedical databases or drug discovery contexts[2]. - FGF7P7 is distinct from the true target FGF7 (Fibroblast growth factor 7, also called keratinocyte growth factor), which is a well-characterized growth factor with defined biological and clinical significance[1][3]. If you intended to refer to FGF7 itself rather than its pseudogene, the correct structured data would be very different. - There is nothing inherently incorrect about the pseudogene’s nomenclature, but using it as a therapeutic target or receptor is incorrect. If you are seeking information on the functional growth factor and not the pseudogene, clarification and a resubmission with the target "fibroblast growth factor 7" or "Keratinocyte growth factor" is recommended.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor 7 pseudogene 7 (FGF7P7).